Published in BMJ on June 15, 1991
Thrombolytic treatment for elderly patients. BMJ (1992) 3.88
Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc (1996) 0.97
The implications of a growing evidence base for drug use in elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction. Br J Clin Pharmacol (2006) 0.81
Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States. Int J Cardiol (2014) 0.77
Incidence of stroke after myocardial infarction. Vasc Health Risk Manag (2006) 0.76
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med (1981) 3.00
Blood-lead and hypertension. Lancet (1976) 2.82
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med (1989) 2.28
Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol (1990) 1.95
Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography. Ann Intern Med (1984) 1.78
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. J Am Coll Cardiol (1990) 1.57
Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke (1977) 1.01
Myocardial infarction coincident with cerebrovascular accidents in the elderly. Age Ageing (1977) 1.01
Stroke after acute myocardial infarction: relation to infarct size. Br Med J (1978) 1.00
Myocardial infarction and stroke. Neurology (1984) 1.00
Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J (1988) 0.97
Cerebrovascular incidents after myocardial infarction. J Neurol Neurosurg Psychiatry (1977) 0.84
Cerebrovascular accidents in acute myocardial infarction. Ital J Neurol Sci (1987) 0.84
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med (2001) 8.74
A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med (1995) 7.88
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging (2005) 4.88
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol (2002) 3.75
The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care (2001) 3.67
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Health services: an Italian market. Lancet (1996) 3.43
Benign infantile familial convulsions. Eur J Pediatr (1992) 2.46
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med (1997) 2.41
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Diversity of the Chlamydia trachomatis common plasmid in biovars with different pathogenicity. Plasmid (1990) 2.19
Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst (1993) 2.16
The EMIP project. European Myocardial Infarction Project. Eur Heart J (2000) 2.15
The teaching and organisation of clinical pharmacology in European medical schools (W.H.O. Working Group on Clinical Pharmacology). Eur J Clin Pharmacol (1990) 2.07
Has clinical pharmacology lost its way? Lancet (1984) 2.02
Office varicose vein surgery under local anesthesia. J Dermatol Surg Oncol (1992) 2.01
Clinical pharmacokinetics of diazepam. Clin Pharmacokinet (1978) 1.99
Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol (1977) 1.94
"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet (1984) 1.87
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) 1.81
Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J Immunol (1998) 1.75
ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation (1995) 1.75
North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet (1998) 1.75
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation (1993) 1.74
Bile duct injuries during laparoscopic cholecystectomy: a 1994-2001 audit on 13,718 operations in the area of Rome. Surg Endosc (2003) 1.68
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 1.68
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Feasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano. Br Med J (Clin Res Ed) (1987) 1.65
Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64
Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br J Clin Pharmacol (1975) 1.63
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Ann Oncol (1997) 1.61
Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med (2005) 1.59
Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators. Eur Heart J (1998) 1.56
Risk factors for myocardial infarction in young women. Am J Epidemiol (1987) 1.55
Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg (2007) 1.55
N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (1975) 1.54
Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet (1984) 1.53
Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ (1993) 1.52
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
Comparability and validity of two clinical scores in the early differential diagnosis of acute stroke. BMJ (1994) 1.49
Second-generation clinical pharmacology. Lancet (1986) 1.49
The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up. Arch Intern Med (1999) 1.48
Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res (1992) 1.47
Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis (2001) 1.45
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet (1998) 1.44
The structure of a plasmid of Chlamydia trachomatis believed to be required for growth within mammalian cells. Mol Microbiol (1988) 1.44
Expression of a plasmid gene of Chlamydia trachomatis encoding a novel 28 kDa antigen. J Gen Microbiol (1993) 1.44
The "T" vein of the leg. Dermatol Surg (2004) 1.40
Caffeine disposition after oral doses. Clin Pharmacol Ther (1982) 1.39
Modified liver hanging maneuver during orthotopic liver transplantation with inferior vena cava preservation: results after 120 consecutive applications. Transplant Proc (2007) 1.39
Benzodiazepines: clinical pharmacology and therapeutic use. Drugs (1980) 1.36
Genome organization of the killer plasmid pGK12 from Kluyveromyces lactis. Nucleic Acids Res (1988) 1.36
Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol (1993) 1.34
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol (1998) 1.31
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe. Eur J Clin Pharmacol (1990) 1.30
Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre. Eur J Clin Pharmacol (1988) 1.28
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol (1999) 1.27
Major and minor injuries during the creation of pneumoperitoneum. A multicenter study on 12,919 cases. Surg Endosc (2001) 1.25
Selective arterial embolization in the treatment of aneurysmal bone cyst and angioma of bone. Skeletal Radiol (1992) 1.25
Loss of FHIT expression in gastric carcinoma. Cancer Res (1998) 1.23
Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation (1996) 1.22
Internet for clinical trials: past, present, and future. Control Clin Trials (1999) 1.21
Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med (1987) 1.20
Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators. Circulation (1992) 1.20
Risk factors for endometrial cancer at different ages. J Natl Cancer Inst (1984) 1.18
Three-dimensional contrastless varicography by spiral computed tomography. Eur J Vasc Endovasc Surg (2001) 1.18
Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators. BMJ (1993) 1.17